LoQus23
Florian Müllershausen - Director
Mathias Frederiksen - Observer
Neuroscience
London, UK
LoQus23 Therapeutics is focusing on targeting DNA damage repair pathways to effectively treat Huntington’s and other triplet repeat diseases.